TrialVaccine2010

Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults.

Mark A Pierce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.